Annual Non Current Assets
$734.33 M
+$518.77 M+240.66%
December 31, 2024
Summary
- As of March 13, 2025, RXRX annual long term assets is $734.33 million, with the most recent change of +$518.77 million (+240.66%) on December 31, 2024.
- During the last 3 years, RXRX annual non current assets has risen by +$658.70 million (+870.99%).
- RXRX annual non current assets is now at all-time high.
Performance
RXRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$734.33 M
+$482.00 M+191.02%
December 31, 2024
Summary
- As of March 13, 2025, RXRX quarterly long term assets is $734.33 million, with the most recent change of +$482.00 million (+191.02%) on December 31, 2024.
- Over the past year, RXRX quarterly non current assets has increased by +$482.00 million (+191.02%).
- RXRX quarterly non current assets is now at all-time high.
Performance
RXRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RXRX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +240.7% | +191.0% |
| 3 y3 years | +871.0% | +191.0% |
| 5 y5 years | +2833.4% | +191.0% |
RXRX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +871.0% | at high | +871.0% |
| 5 y | 5-year | at high | +2833.4% | at high | +2184.2% |
| alltime | all time | at high | +2833.4% | at high | +2184.2% |
Recursion Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $714.27 M(+63.0%) | $734.33 M(+191.0%) |
| Sep 2024 | - | $252.33 M(-0.5%) |
| Jun 2024 | - | $253.49 M(+18.3%) |
| Mar 2024 | - | $214.23 M(-0.6%) |
| Dec 2023 | $438.14 M(-23.1%) | $215.56 M(-2.2%) |
| Sep 2023 | - | $220.30 M(-6.5%) |
| Jun 2023 | - | $235.68 M(+74.3%) |
| Mar 2023 | - | $135.24 M(+2.9%) |
| Dec 2022 | $569.81 M | $131.47 M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $129.91 M(+2.7%) |
| Jun 2022 | - | $126.52 M(+10.1%) |
| Mar 2022 | - | $114.86 M(+51.9%) |
| Dec 2021 | $534.72 M(+100.7%) | $75.63 M(+31.0%) |
| Sep 2021 | - | $57.74 M(+13.3%) |
| Jun 2021 | - | $50.95 M(+1.7%) |
| Mar 2021 | - | $50.12 M(+55.9%) |
| Dec 2020 | $266.44 M(+248.7%) | - |
| Dec 2020 | - | $32.15 M |
| Dec 2019 | $76.40 M | - |
FAQ
- What is Recursion Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual non current assets year-on-year change?
- What is Recursion Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly non current assets year-on-year change?
What is Recursion Pharmaceuticals annual long term assets?
The current annual non current assets of RXRX is $734.33 M
What is the all time high annual non current assets for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual long term assets is $734.33 M
What is Recursion Pharmaceuticals annual non current assets year-on-year change?
Over the past year, RXRX annual long term assets has changed by +$518.77 M (+240.66%)
What is Recursion Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of RXRX is $734.33 M
What is the all time high quarterly non current assets for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly long term assets is $734.33 M
What is Recursion Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, RXRX quarterly long term assets has changed by +$482.00 M (+191.02%)